Nature medicine
Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.
Jennifer M Kwon, Francina Munell, Laure Le Goff, Kotaro Yuge, Tamaki Kato, Claude Cances, Liesbeth De Waele, Ian R Woodcock, Eugenio M Mercuri, Crystal M Proud, Basil T Darras, Leslie H Hayes, Maryam Oskoui, Jeannie Visootsak, Gemma Williams
Published: 202610.1038/s41591-026-04233-9
No abstract available for this study.